Stocks
Bristol-Myers (BMY) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 43.4% | 41.6% | 43.0% | 6.56% | 31.6% | 28.4% | ||
| Changes by years, y/y, % | +32pp | -2pp | +1pp | -36pp | +25pp | +22.2% | |||
Bristol-Myers. EBITDA margin, %
Bristol-Myers. EBITDA margin, changes, pp
Bristol-Myers (BMY) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EBITDA margin, % | ? | 26.8% | 37.7% | 23.0% | 36.9% | 38.1% | 28.4% | |
| Changes by years, y/y, % | -9pp | -2pp | +2pp | -3pp | +11pp | |||
| Changes by quarters, q/q, % | -13pp | +11pp | -15pp | +14pp | +1pp | |||
